Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000298672 is an uncharacterized long non-coding RNA gene annotated as a “novel transcript, sense intronic to NTM.” It is an intronic lncRNA located within the Neurotrimin (NTM) gene locus, discovered through high-throughput annotation efforts. There is no published data on its function, biological processes, disease associations, druggability, or biomarker status. The transcript is not recognized as a therapeutic target, receptor, enzyme, transporter, or other classical drug target family, and resembles other novel lncRNAs catalogued for completeness in genome annotation studies. Until further experimental or biological characterization is available, it should not be considered a validated target for therapeutic or diagnostic applications[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to NTM.